Latest Clinical Trials
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
Various researchers have chronicled how our understanding of idiopathic pulmonary fibrosis has undergone tremendous changes over the years.
Researchers explain why they believe visual analog scales are ideal assessment tools for understanding patients’ experiences.
We explore the vast medical challenge of treating the combination of idiopathic pulmonary fibrosis and pulmonary hypertension successfully.
We explore how telomere dysfunction potentially drives the pathogenesis of idiopathic pulmonary fibrosis, and what that could mean for future research.
We explore the pathological processes that result in the fibrosis of the lungs in patients with idiopathic pulmonary fibrosis.
We explore a proposed medical algorithm for diagnosing acute exacerbations of IPF and discuss the use of medical algorithms in general.
Extracellular vesicles (EVs) have been implicated in the pathogenesis of a variety of chronic respiratory diseases, including alpha-1 antitrypsin deficiency (AATD) and idiopathic pulmonary fibrosis (IPF). Their role in disease progression makes them an interesting target for diagnostic and therapeutic interventions. The multiple potential functions of EVs in these diseases are discussed by Purghè et…
We know that pathological extracellular matrix (ECM) changes occur in idiopathic pulmonary fibrosis. What drives that, and what can we do about it?
Researchers uncover more evidence regarding the detrimental effects of air pollution on acute exacerbations of idiopathic pulmonary fibrosis.
We explore how our understanding of the pathophysiology and treatment of idiopathic pulmonary fibrosis has changed in recent decades.
Rare Care Podcast
Diagnosing and Treating IPF: Insights From Noah Greenspan, DPT, founder of New York City’s Pulmonary Wellness & Rehabilitation Center.
IPF Meeting Coverage